Bielefeld, Germany

Rainer Schmuck

This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rainer Schmuck. Retrieved from https://idiyas.com/inventor/rainer-schmuck-1xsko6x3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 61(Granted Patents)


Company Filing History:


Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rainer Schmuck: Innovator in Proteinase Inhibition

Introduction

Rainer Schmuck is a notable inventor based in Bielefeld, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of proteinase inhibitors. His work has implications for various medical and therapeutic applications.

Latest Patents

Rainer Schmuck holds a patent for "Homologues of aprotinin with, in place of lysine, other amino acids." This invention relates to homologs of aprotinin that incorporate different amino acid moieties in position 15. The methods for their preparation and their use as proteinase inhibitors are key aspects of this patent. He has 1 patent to his name.

Career Highlights

Rainer Schmuck is associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His role at Bayer has allowed him to work on innovative projects that advance the understanding and application of proteinase inhibitors.

Collaborations

Throughout his career, Rainer has collaborated with esteemed colleagues such as Harald Tschesche and Eugen Schnabel. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion

Rainer Schmuck's contributions to the field of proteinase inhibition highlight his innovative spirit and dedication to scientific advancement. His work continues to influence the development of therapeutic solutions in biochemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…